首页> 外国专利> LACTOBACILLUS BREVIS AND LACTOBACILLUS RHAMNOSUS STRAINS WITH ESTABLISHED GENOMIC SEQUENCY SYNTHESIZING GLUTATHION AND INTRACELLULAR ANTIOXIDANTS COMPLEX

LACTOBACILLUS BREVIS AND LACTOBACILLUS RHAMNOSUS STRAINS WITH ESTABLISHED GENOMIC SEQUENCY SYNTHESIZING GLUTATHION AND INTRACELLULAR ANTIOXIDANTS COMPLEX

机译:具有确定的基因序列合成谷胱甘肽和胞内抗氧化剂的牛乳杆菌和鼠李糖乳杆菌菌株

摘要

FIELD: biotechnology.;SUBSTANCE: group of inventions concerns Lactobacillus brevis 47f, Lactobacillus rhamnosus 313, Lactobacillus rhamnosus 40f And Lactobacillus brevis 15f strains capable of synthesizing glutathione antioxidant. The strains are deposited in the All-Russian Collection of Industrial Microorganisms under the registration numbers VKPM B-12237, VKPM B-12236, VKPM B-12238 and VKPM B-12077, respectively. The invention includes isolation, identification, description of properties and nucleotide sequence of the genes. The strains can be used for preparation of accompaniments for cancer patients chemotherapy for drug enteropathy and concomitant diseases prevention and treatment.;EFFECT: group of inventions can prevent severe complications of drug enteropathy.;4 cl, 1 dwg, 9 tbl, 12 ex
机译:领域:生物技术:一组发明涉及能够合成谷胱甘肽抗氧化剂的短乳杆菌47f,鼠李糖乳杆菌313,鼠李糖乳杆菌40f和短乳杆菌15f菌株。菌株分别以注册号VKPM B-12237,VKPM B-12236,VKPM B-12238和VKPM B-12077保藏在全俄工业微生物收藏中。本发明包括基因的分离,鉴定,特性和核苷酸序列的描述。该菌株可用于为癌症患者化疗药物性肠病及伴随疾病的预防和治疗制备佐剂。效果:本发明组可预防药物性肠病的严重并发症。4cl,1 dwg,9 tbl,12 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号